Dengue Virus (1-4) Subtype by PCR
Also known as: DENGUEPCR
Use
This test is used to detect and differentiate dengue virus subtypes 1-4, which are mosquito-borne arboviruses. It is beneficial for diagnosing dengue fever, commonly known as breakbone fever, a viral infection transmitted by mosquitoes. Early and accurate detection of the specific dengue subtype can aid in patient management and treatment decisions, as well as in public health efforts to control the spread of the disease.
Special Instructions
This test is approved by New York state. It involves the collection of specimens in Lavender (EDTA), Pink (K2 EDTA), or Serum Separator Tube (SST). The assay requires separating serum or plasma from cells, followed by freezing the samples for transport. Specimen source must be stated.
Limitations
A negative result does not preclude the presence of PCR inhibitors in the specimen, nor does it exclude the presence of dengue virus nucleic acid at levels below the assay's detection limit. The test has not been cleared or approved by the FDA but is performed in a CLIA certified lab for clinical purposes.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
LOINC Codes
- 31208-2
- 60262-3
- 60420-7
- 60419-9
- 60418-1
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.5 mL
Container
Sterile container
Collection Instructions
Separate serum or plasma from cells.
Storage Instructions
Frozen
Causes for Rejection
Heparinized specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 5 days |
| Frozen | 2 weeks |
Other tests from different labs that may be relevant